Abstract
Several aspects of mitotic spindle assembly are orchestrated by the Ran GTPase through its modulation of the interaction between spindle assembly factors and importin-α. One such factor is TPX2 that promotes microtubule assembly in the vicinity of chromosomes. TPX2 is inhibited when bound to importin-α, which occurs when the latter is bound to importin-β. The importin-α:β interaction is disrupted by the high RanGTP concentration near the chromosomes, releasing TPX2. In more distal regions, where Ran is predominantly GDP-bound, TPX2 remains bound to importin-α and so is inhibited. Here we use a combination of structural and biochemical methods to define the basis for TPX2 binding to importin-α. A 2.2 Å resolution crystal structure shows that the primary nuclear localization signal (284KRKH287) of TPX2, which has been shown to be crucial for inhibition, binds to the minor NLS-binding site on importin-α. This atypical interaction pattern was confirmed using complementary binding studies that employed importin-α variants in which binding to either the major or minor NLS-binding site was impaired, together with competition assays using the SV40 monopartite NLS that binds primarily to the major site. The different way in which TPX2 binds to importin-α could account for much of the selectivity necessary during mitosis because this would reduce the competition for binding to importin-α from other NLS-containing proteins.
Keywords: Crystal Structure, Mitosis, Mitotic Spindle, Nuclear Transport, Protein-Protein Interactions, X-ray Crystallography, TPX2, Importin
Introduction
In many species, the generation of the mitotic spindle is orchestrated by the RanGTPase (1–4), which, during interphase, powers many nuclear trafficking pathways (5, 6). In both mitosis and nuclear trafficking, Ran functions by modulating the interaction between nuclear transport factors and a range of target proteins. Thus, in nuclear protein import, for example, cargo proteins destined for nuclear import bind to transport factors (importins) in the cytoplasm, where Ran is in the GDP-bound form. This cargo:carrier complex then equilibrates between the two compartments through nuclear pore complexes (NPCs). In the nucleus, RanGTP dissociates the import complex, releasing the cargo, after which the transport factors are recycled to the cytoplasm where the Ran GTP is hydrolyzed, freeing the transport factors for another import cycle. However, during an open mitosis, the nuclear envelope is disassembled and instead Ran and some nuclear transport factors are used to orchestrate microtubule dynamics related to spindle generation (reviewed in Ref. 3).
TPX2 (target protein for Xenopus kinesin-like protein 2)3 is a microtubule assembly factor involved in chromatin-promoted spindle assembly and this activity is orchestrated by Ran (1, 7–10). Ran is maintained in the GTP-bound form near the chromosomes, but is in the GDP-bound form in more distal regions (11). In the absence of RanGTP, the nuclear protein import factor importin-β binds to the importin-α adaptor, and this interaction frees importin-α to bind molecules such as TPX2 that have a nuclear localization sequence (NLS). A common form of NLS is the “classical” NLS that contain one (“monopartite”) or two (“bipartite”) clusters of basic residues (12). The microtubule assembly function of TPX2 is inhibited when it is sequestered by importin-α. However, in the vicinity of the chromosomes, RanGTP binds to importin-β, releasing importin-α. The importin-β binding domain of importin-α (the IBB domain) in combination with other factors (6, 12–15) then displaces NLS-containing cargoes such as TPX2, freeing them to participate in spindle assembly, as illustrated schematically in Fig. 1. It was originally proposed that TPX2 functioned in spindle assembly through an interaction between its N terminus and the Aurora A kinase (1). This interaction is important in regulating Aurora A activity and, for example, the reduced cellular activity and mislocalization the Aurora A(S155R) mutant protein are because of loss of interaction with TPX2 (16). However, subsequent studies have indicated that the C terminus of TPX2 is crucial for its microtubule nucleation function, possibly by way of interacting with the kinesin-like protein Xklp2 and targeting it to the spindle poles (17–19) and/or by influencing kinetochore-associated microtubule formation (10). Overall, TPX2 appears to represent a key node in a complex network of protein:protein interactions that is required for spindle assembly (10, 17).
Previous work on the binding of classical NLSs to importin-α has established consensus sequence motifs for both monopartite and bipartite NLSs and has examined the contributions made by the different side chains involved (reviewed in Ref. 12). Importin-α is a banana-shaped molecule constructed from a series of tandem “ARM” repeats, each of which is based on a motif containing three α-helices (20). NLSs bind to the inner concave surface of importin-α through interactions with a series of strategically located Trp, Asn, and acidic residues (reviewed in Refs. 5, 6, 12). In addition to the ARM repeats, importin-α also has a region of ∼70 residues at its N terminus that binds to importin-β. This importin-β-binding domain (IBB) also has an auto-inhibitory role such that, when it is not bound to importin-β (most commonly when RanGTP is bound to importin-β), it can bind to the inner surface of importin-α and reduce its affinity for bound NLSs (13). Dissociation of the NLS is then completed using additional factors, such as Cse1/CAS (5, 6).
NLSs are either monopartite, consisting of a single cluster of positively charged residues, or bipartite, based on two positively charged clusters separated by ∼10 residues, although in some cases somewhat longer linkers have been observed (21). The residues binding to the major site are designated P1-P5 and those binding to the minor site as P′1-P′4 (Fig. 3D). Monopartite NLSs bind primarily to a site, generally referred to as the “major NLS-binding site,” located on ARM repeats 2–4, whereas bipartite NLSs bind to both this site and a second “minor” site, located on ARM repeats 7 and 8 (20, 22, 23). However, monopartite NLSs also bind to the minor site, but with lower affinity (20, 22, 23). Extensive mutagenesis and biophysical studies (23–30; reviewed in Ref. 12) have established the contributions made to the interaction by residues located at the different positions within the NLSs. It is crucial to have Lys in position P2 (25) to enable salt-bridge formation with Asp-192 and even mutation to Arg shows greatly reduced nuclear accumulation (29). Position P4, conversely, makes a smaller contribution to the binding energy (25) and shows much greater variability between different NLSs. Positions P3 and P5 are usually Lys or Arg and make intermediate contributions to the binding energy (25). The binding of Lys and Arg in positions P′1 and P′2 is thought to be the primary interaction at the minor NLS-binding site, with reduced contributions being made by the residues at positions P′3 and P′4 (24, 25, 27).
Although TPX2 binds to importin-α, it does not contain a classical NLS and instead employs a sequence including Lys-284 and Arg-285 (31). Mutation of these residues prevents importin-α from inhibiting TPX2-mediated microtubule assembly, as does mutation of the two sites on importin-α that are responsible for binding NLSs (7, 31). It is to some extent paradoxical that importin-α can inhibit TPX2 so effectively in mitotic cells because a great number of normally nuclear proteins that contain classical NLSs will become accessible following nuclear envelope breakdown. Here we characterize the TPX2:importin-α interaction more fully, using a combination of structural and biochemical approaches, to establish how TPX2 binds to importin-α. We find two regions of TPX2 that interact with importin-α, one of which contains primarily residues 284–287 identified earlier (31), and a second region that contains primarily residues 327–330. Of these regions, residues 284–287 bind more strongly and are the primary determinant of the interaction. However, these residues unexpectedly bind to the minor NLS-binding site on importin-α rather than the major site. Instead, residues 327–330 bind to the major NLS-binding site even though they do not correspond closely to the consensus binding sequence seen with classical monopartite NLSs. The predominant role of the minor NLS-binding site in the TPX2:importin-α interaction may account to some extent for ability of importin-α to bind TPX2 in the presence of many other proteins that contain a monopartite NLS and opens the possibility of generating small molecule inhibitors that may selectively inhibit this interaction.
EXPERIMENTAL PROCEDURES
Expression and Purification of the TPX2-NLS:ΔIBB-Importin-α Complex
A fragment (TPX2270–350) corresponding to residues 270–350 of Xenopus TPX2 (GI: 46249461) was cloned into pGEX-TEV (14) and expressed as GST fusions in Escherichia coli BL21(DE3) CodonPlus RIL cells at 20 °C overnight. Untagged mouse importin-α lacking the IBB domain (residues 70–529, ΔIBB-importin-α) was expressed as described (15). All subsequent steps were performed at 4 °C. After harvesting, the two sets of cells were lysed in 50 mm Tris-HCl (pH 7.4), 200 mm NaCl, 2 mm DTT by high-pressure cavitation (15k psi). Clarified cell lysates were mixed and incubated with glutathione-Sepharose for 1 h. After washing the beads extensively, the complex was released from the resin by overnight digestion with His-TEV protease (S219V mutant; Ref. 32). The complex was further purified by gel filtration on a Superdex 75 26/60 column in 20 mm Tris-HCl (pH 7.4), 100 mm NaCl, and 2 mm DTT and concentrated to 20 mg/ml.
Cloning, Expression, and Purification of Proteins for Biochemical Assays
GST fusions containing the SV40 NLS or nucleoplasmin NLS were expressed and purified as described (33). GST-TPX2270–289 and GST-TPX2290–350 were expressed from pGEX-TEV, whereas TPX2276–291-GFP and TPX2276–351-GFP were expressed from pET28a. Xenopus and mouse ΔIBB-importin-α constructs were expressed from pET30a as His/S-fusions. The cDNAs employed were for mouse: importin-α1, GI: 13879578; importin-α3, GI: 20073210; mouse-α4, GI: 2007072; importin-α6, GI: 13436001; and importin-α2; GI: 6754474; for Xenopus: importin-α1a, GI: 67678145; importin-α2, GI: 27696874; and importin-α5.2, GI: 48734621. Mutations in Xenopus ΔIBB-importin-α1a and mouse ΔIBB-importin-α2 were introduced by site-directed mutagenesis to create the following mutant constructs: mouse ΔIBB-importin-αED (D192K/E396R), mouse ΔIBB-importin-αE (E396R), mouse ΔIBB-importin-αD (D192K), Xenopus ΔIBB-importin-αED (D189K, E389R), Xenopus ΔIBB-importin-αED (E389R), and Xenopus ΔIBB-importin-αD (D189K). The resultant cDNAs were then cloned into pET30a using BamHI and EcoRI sites.
All constructs were verified by sequencing. Recombinant proteins were expressed in BL21(DE3) CodonPlus RIL cells at 20 °C overnight. His/S tagged importin-α constructs, TPX2276–291-GFP, and TPX2276–351-GFP were purified over Ni-NTA (Qiagen) following the manufacturer's protocols. Proteins were further purified by gel filtration over Superdex 75 in 20 mm Tris-HCl (pH 7.4), 100 mm NaCl, and 5 mm 2-mercaptoethanol. GST fusion proteins for pull-down experiments were purified over glutathione-Sepharose 4B (Amersham Biosciences) as described by the manufacturer.
In Vitro Pull-down Assays
For standard pull-down assays, clarified bacterial cell lysates expressing the respective GST fusions were bound to glutathione-Sepharose and incubated with cell lysates expressing the various importin-α constructs. For competition pull-down experiments, GST-NLS fusion proteins (4.5 μg) were bound to 10 μl of glutathione Sepharose and incubated with ΔIBB-importin-α (10 μg) ± 30 μm of the indicated TPX2-GFP constructs in 100 μl of binding buffer (PBS, 0.1% Tween-20 and 2 mm DTT) for 1 h at 4 °C. Beads were washed 3× in 500 μl of binding buffer, and bound proteins were subsequently eluted with SDS-sample buffer. Bound and unbound fractions were analyzed on SDS-PAGE gels stained with Coomassie Blue.
Crystallography
Crystals of the TPX2:importin-α complex were obtained by hanging drop vapor diffusion in which 2-μl drops of protein solution were mixed with 2 μl drops of well buffer containing 100 mm Tris-HCl (pH 7.0), 1.1–1.2 m ammonium sulfate and 10 mm DTT and equilibrated in Linbro plates at 18 °C. Diffraction data were collected from single crystals soaked briefly in crystallization buffer supplemented with 20% glycerol and flash frozen at 100 K in a nitrogen stream. A native data set was obtained using beamline ID29 at the European Synchrotron Research facility (ESRF), Grenoble, France (Table 1). The crystals had P212121 orthorhombic symmetry with and were isomorphous to the crystals formed by the complex between importin-α: and the nucleoplasmin NLS (Ref. 23; PDB accession code 1EYJ). The importin-α chain was positioned by rigid body refinement and then subjected to iterative cycles of refinement and rebuilding using PHENIX (34) with TLS (35) and COOT (36), after which there was clear difference density located in both NLS-binding pockets and many side chains of the bound peptide could be identified unequivocally. TPX2 residues 283–288 were built into the density located at the minor site whereas residues 322–331 were built into the major site. There was very clear side-chain density for the residue in position P1 in the major NLS-binding site, which confirmed that the principal TPX2 NLS was not bound in this position (because the corresponding residue would be Gly). A final model was obtained after further cycles of refinement and rebuilding and the addition of five sulfate ions and 227 waters. Table 1 gives the crystallographic statistics.
TABLE 1.
Crystals | |
Symmetry | P212121 |
a, b, c (Å) | 78.53, 89.32, 99.27 |
Data collection | |
Wavelength (Å) | 0.9814 |
Resolution range (Å)a | 27.85–2.2 (2.32–2.2) |
Total observationsa | 248850 (35541) |
Unique observationsa | 36138 (5187) |
Completeness (%)a | 99.9 (100) |
Multiplicity | 6.9 (6.9) |
Rpim (%)a | 4.6 (39.9) |
Mean I/σ(I)a | 11.7 (2.2) |
Refinement | |
Rcryst/Rfree (%) | 18.8/21.2 |
Bond length rmsd (Å) | 0.003 |
Bond angle rmsd (°) | 0.75 |
MolProbity score/percentile | 1.24/100 |
Ramachandran plot (%) | |
Favored | 99.1 |
Allowed | 0.9 |
Forbidden | 0 |
PDB accession number: | 3KND |
a Parentheses refer to final resolution shell.
The atomic coordinates and structure factors (code 3KND) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ.
RESULTS
Residues 270–289 of TPX2 Bind to a Range of Importin-α Isoforms
Nuclear localization sequences usually bind to a broad range of different importin-α isoforms from different species (12, 37, 38). Both the SV40 monopartite NLS and nucleoplasmin bipartite NLS, for example, bind to yeast and mammalian importin-α. However, the Xenopus TPX2 NLS that binds to importin-α involves a sequence around two basic residues at positions 284 and 285 that does not fit the classical NLS consensus (31). Although the precise boundaries of the TPX2 NLS had not been established in earlier work, we found that a fragment containing residues 270–289 (TPX2270–289) was able to bind a range of vertebrate importin-α constructs from which the autoinhibitory IBB domain had been deleted (Fig. 2). The ΔIBB-importin-α constructs mimic the importin-α:β complex that binds NLSs in vivo (12). Thus, GST-TPX2270–289was able to bind specifically to ΔIBB constructs of Xenopus importin-α1a, -α2, and -α5.2 and also mouse importin-α1, -α2, -α4, and -α6, from crude bacterial lysates, whereas negligible binding was seen to GST alone. This result was consistent with the TPX2 NLS having the broad binding specificity seen with classical NLSs.
Crystal Structure of a TPX2:Importin-α Complex
Attempts to crystallize ΔIBB-importin-α complexed with TPX2276–289 only resulted in very small crystals that were not suitable for data collection. Therefore, we screened complexes of ΔIBB-importin-α bound to a range of longer TPX2 fragments and found that the complex formed with TPX2 residues 270–350 yielded crystals with P212121 orthorhombic symmetry that diffracted to 2.2 Å resolution using synchrotron radiation (Table 1). The crystals were isomorphous with those obtained previously for the importin-α:nucleoplasmin-NLS complex (Ref. 23; PDB accession number 1EYJ) and rigid body refinement enabled the importin-α chain to be modeled using the structure determined previously. After initial refinement and rebuilding, there was clear density located over both the minor and major NLS binding pockets (Fig. 3A). Although this density was not continuous, the sequence of fragments corresponding to residues 283–288 and 322–331 of TPX2 could be built easily into the difference density and, after adding five sulfates and 227 waters, resulted in a final structural model with an R-factor of 18.3% (Rfree 21.2%), excellent geometry (Table 1) and a MolProbity (39) score of 1.24 (100th percentile). No reliable electron density was seen for the remaining residues in the TPX2 fragment.
The structural model (Fig. 3) showed that the primary TPX2 NLS, comprising residues 284–287 (KRKH, Ref. 31) was bound to the “minor” NLS-binding site on importin-α (located primarily in ARM repeats 7 and 8), whereas TPX2 residues 327–330 (KMIK) were bound to the “major” NLS-binding site (located primarily in ARM repeats 2–4). Density from several residues outside this range was also visible, but was weaker, consistent with these two four-residue regions forming the principal interfaces between the TPX2 peptide and importin-α. Fig. 3 shows the details of the interaction at each site, together with a comparison with the interactions seen with the nucleoplasmin NLS (23). The TPX2 residues at the minor site formed an extensive network of interactions with importin-α. Lysine 284 in position P′1 formed H-bonds with Thr-328, Ser-361 and the main-chain carbonyl of Val-321; the side chain of Arg-285, in position P′2, was sandwiched between the indole rings of Trp-357 and Trp-399 and formed a salt-bridge to Glu-396; Lys-286, in position P′3, formed H-bonds with Thr-322 and Asn-283 and also to the main chain of Gly-281; and His-287, in position P′4, formed a salt bridge with Glu-354 and extensive hydrophobic/π interactions with Trp-357. Additional H-bonds were formed to the NLSs main chain by Trp-357and Gln-361. In the major NLS-binding site, Lys-327, in position P2, formed a salt bridge with Asp-192, together with H-bonds to Thr-155 and the main-chain carbonyl of Gly-150; Met-328, in position P3, was sandwiched between the indole rings of Trp-184 and Trp-223 in a conformation similar to that seen with Lys or Arg in classic NLSs; and Lys-330, in position P5, was sandwiched between the indole rings of Trp-142 and Trp-184. There were also a series of H-bonds formed between the main-chain carbonyls of the NLS and Asn-146, Asn-188, and Asn-235. Ser-324 also formed H-bonds with Arg-238 and Tyr-277.
Importin-α Variants Confirm that TPX2283–287 Binds to the Minor NLS-binding Site
Previous work showed that specific point mutations in importin-α can inhibit binding in either the major or minor NLS-binding site selectively (7, 28, 31). Thus, in yeast (28), the D203K variant inhibits binding to the major site whereas E402R inhibits binding to the minor site (the equivalent mutants in mouse and Xenopus importin-α are D192K/E396R and D189K/E389R, respectively). We therefore constructed the corresponding mouse and Xenopus ΔIBB importin-α variants that contained mutations in the major (ΔIBB-importin-αD) and minor (ΔIBB-importin-αE) NLS binding site either individually, or in both sites (ΔIBB-importin-αED) simultaneously. These variants were then tested for their ability to bind to the TPX2270–289and TPX2270–350 NLS constructs and also to the monopartite SV40 NLS and bipartite nucleoplasmin NLS as controls.
GST-NLS fusions were coupled to glutathione Sepharose and used for pull-down experiments with the ΔIBB-importin-α variants. None of the ΔIBB-importin-α variants bound to GST alone (data not shown). Both Xenopus and mouse ΔIBB-importin-α bound the TPX2270–289and TPX2270–350 NLS fragments in a similar manner (Fig. 4, A and B). Although the TPX2, SV40, and nucleoplasmin NLSs all bound wild-type Xenopus and mouse ΔIBB-importin-α, no binding could be detected for any NLS to the ΔIBB importin-αED mutant. Consistent with previous work (28, 37), the nucleoplasmin and the SV40 NLS still bound the ΔIBB-importin-αE variants, but did not bind the D variant. In contrast, both TPX2 NLS fragments interacted efficiently with the D variant but not with the E variant, confirming that TPX2284–287 binds primarily to the minor NLS-binding site of importin-α.
TPX2284–287 Represents the Principal Importin-α-binding Site
Because the crystal structure of the TPX2:importin-α complex identified two TPX2 regions that bind to importin-α, we investigated the relative contribution made by each site. GST fusions containing either TPX2270–289 or TPX2290–350 were bound to glutathione-Sepharose and probed with ΔIBB-importin-α (Fig. 5). A control fragment containing both TPX2-binding segments (TPX2270–350) and also TPX2270–289 were able to pull-down ΔIBB-importin-α from bacterial lysates. In contrast, the TPX2290–350 fragment that contained only the second TPX2 importin-α-binding region was not able to pull down importin-α, indicating that removing TPX2284–287 reduced the binding of TPX2 to importin-α dramatically. Therefore, the binding site on TPX2 containing residues 284–287 is crucial for the interaction with importin-α.
Competition for Importin-α
We used a pull-down assay to evaluate the extent to which TPX2 and other NLSs competed for binding to ΔIBB-importin-α. Immobilized GST- SV40 NLS or GST-nucleoplasmin NLS was incubated simultaneously with Xenopus ΔIBB-importin-α and TPX2 NLS fragments consisting of either both binding sites (TPX2284–287 and TPX2327–330) or TPX2284–287 alone fused to the N terminus of GFP (TPX2276–291-GFP or TPX2276–351-GFP, respectively). In the presence of TPX2284–287, only a small amount of ΔIBB-importin-α was displaced from the SV40 NLS, as evidenced by the decrease in ΔIBB-importin-α in the fraction remaining bound to the beads after centrifugation, and a corresponding increase in the unbound fraction that remained in solution (Fig. 6). However, despite its being somewhat degraded by proteolysis, the TPX2276–351 fragment containing both binding sites displaced most of the ΔIBB-importin-α from SV40 NLS, so that only a small amount of ΔIBB-importin-α remained bound while the concentration of ΔIBB-importin-α in the unbound fraction increased markedly. The TPX2276–291 only displaced a small amount of ΔIBB-importin-α bound to the nucleoplasmin-NLS, but considerably more ΔIBB-importin-α was displaced, as evidenced by the increase in ΔIBB-importin-α in the unbound fraction when the TPX2276–351 fragment that contained both sites was employed. The TPX2276–351 fragment was very labile to proteolysis, even in the presence of a mixture of inhibitors, probably because it was mainly unstructured in solution. However, even in its degraded form it was able to compete for binding to ΔIBB-importin-α to a considerable extent. The nucleoplasmin NLS has a higher affinity for ΔIBB-importin-α than the SV40 NLS (12, 15, 24, 25), and so it was to be expected that it would be more difficult for TPX2 to displace it.
DISCUSSION
Both the crystal structure of the TPX2:importin-α complex and the binding studies with importin variants support the primary TPX2 NLS (284KRKH287) binding to the minor NLS-binding site on importin-α. Moreover, the binding studies indicate that this interaction makes a greater contribution to the binding than the interaction seen between TPX2 327KMIK330 and the major NLS binding site. This is the converse to the usual observation with bipartite NLSs, where the interaction with the major NLS-binding site makes the greater contribution.
Neither interaction observed with the two TPX2 regions that bound to importin-α was typical of that seen with other NLSs bound to importin-α. The crystal structures of NLSs derived from nucleoplasmin (23), neuroblastoma protein (27), phosphoprotein N1N2 (27), and CBP80 (40) bound to importin-α have been obtained. All of these classical bipartite NLSs had a cluster of positively-charged residues (KKKK, KKLR, KKSK, and KRRK, respectively) bound to positions P2-P5 of the “major” NLS-binding site. In contrast, TPX2 bound KMIK at the major site and so retained a positively charged side chain only at positions P2 and P5. However, although this sequence does not fit the consensus binding motif for the major NLS binding site, many of the interactions observed with both bipartite and monopartite NLSs with the major binding site on importin-α were preserved, especially those that extensive mutagenesis studies (24, 25) have shown to be more important for binding. Thus, Lys-327 in position P2, which has been shown to make the most important contribution to the binding energy (25), forms a salt-bridge with Asp-192 and there is a series of H-bonds between the TPX2 main chain carbonyls and Asn-145, Asn-188, and Asn-235. Moreover, Lys-330 in position P5, which makes the next most-important contribution, is also conserved. In position P3, Met-328 is sandwiched between Trp-184 and Trp-231 analogous to the way in which a Lys or Arg chain is usually positioned (23, 27). Although this interaction would lack the cation-π interaction (41) seen conventionally, the contribution made from the hydrophobic interaction would be still substantial.
The interaction between the TPX2 NLS and the “minor” NLS-binding site on importin-α is much more extensive than observed with typical classical NLSs. Although the binding of Lys-284 and Arg-285 in positions P′1 and P′2, respectively, is similar to that observed with bipartite classical NLSs, Lys-286 and His-287 also make extensive interactions with importin-α. Thus, in addition to the contribution due to burying hydrophobic surfaces, Lys-286, in position P′3, forms H-bonded networks with Gly-281, Asn-283, and Thr-322, whereas His-287, in position P′4, forms a putative salt bridge with Glu-354 as well as an extensive cation-π interaction (41) with Trp-357. Although the 40 residues separating the two importin-α binding clusters on TPX2 is much greater than the 10–12 more commonly observed for bipartite NLSs, there are examples of longer linkers that can be accommodated provided they are sufficiently flexible (21).
Recent work (37, 38) has used a universal GFP expression system to screen random peptide libraries to identify six classes of NLS that bind to importin-α. Three of these classes corresponded to the classical monopartite (classes 1 and 2) and bipartite (class 6) NLSs, whereas class 5 was plant-specific. However, two classes were identified that appeared to bind preferentially to the minor NLS-binding site on importin-α. Class 3 had the consensus sequence KRX[WFYH]XXAF, whereas class 4 had the consensus [RP]XXKRR[KR][-DE], where X represents any residue, square brackets indicate any of the residues that can be found at that position, and “-” indicates residues that are not found at the position. Neither monopartite (classes 1 and 2) consensus sequence corresponds to the TPX2 sequence 327KMIK330 found at the major site, nor does either minor site NLS consensus sequence (classes 3 and 4) match the TPX2284–287 KRKH sequence. However, His-287 could correspond to the large hydrophobic residue often found at position 4 in the class 3 consensus and which has been found to be effective for nuclear protein import in yeast (38), although these experiments did not distinguish between major and minor site binding. Interestingly, in class 3, sequences with a consensus RKX[WFY]XXAF (in which the K and R in positions 1 and 2 were exchanged) or in which the R in position 2 was mutated to any other residue showed greatly reduced binding to importin-α, consistent with the crucial roles of these residues in the TPX2 sequence.
Although the TPX2284–287 NLS is based on four consecutive positively charged residues (KRKH), it clearly does not bind strongly to the major site on importin-α. In classical NLSs, a Lys or Arg in position P5 forms a prominent cation-π interaction with importin-α Trps 142 and 184 that makes a considerable contribution to the binding energy that is second only to that made by the Lys in position P2 (25). Although His-287 is also positively charged, the charge is located closer to the NLS main chain than with Lys or Arg and is more distant from Gln-181 with which these residues form a putative H-bond. This, combined with the rigidity of the imidazole ring, probably result in His-287 making a considerably reduced contribution to the binding energy of the TPX2284–287 NLS to the major NLS-binding site on importin-α. An analogous sequence may function in the C-terminal kinesin XCTK2 that is important for spindle assembly. XCTK2 is inhibited by importin-α and here the sequence 19KRKY22 is crucial for the interaction (42). Although it has not been established whether XCTK2 binds primarily to the minor NLS-binding site on importin-α, it is likely that here Tyr-22 could function similarly to His-287 in TPX2.
The atypical way in which TPX2 binds to importin-α, with the more important interaction taking place at the minor NLS-binding site, would reduce the competition for binding from other proteins containing NLSs, especially the more common monopartite variety exemplified by SV40 (12) that binds primarily to the major NLS-binding site on importin-α. In the bulk of the cytoplasm, away from the chromosomes, the RanGTP concentration is too low to dissociate the importin-α:β complex which is then able to bind TPX2 and inactivate it (7–10). It is in this region that competition from other NLSs could potentially cause a problem because if importin-α were to be saturated with other NLSs this could inhibit its binding to TPX2 and inactivating it. This could in turn lead to aberrant spindle formation away from the chromosomes. By contrast, near the chromosomes, where the RanGTP concentration is elevated (11), RanGTP binds to importin-β leading to the release of TPX2 locally to participate in spindle assembly. However, because monopartite NLSs still bind to the minor site on importin-α with reduced affinity (22, 23), adding a large excess, especially of a polydentate conjugate of NLSs with BSA, would still have the potential to displace TPX2 from importin-α as observed by Schatz et al. (31). Moreover, although nucleoplasmin binds more strongly to importin-α than the SV40 NLS (12, 15, 23–27), during mitosis this protein is heavily phosphorylated and also binds strongly to histones, both of which may impede its binding to importin-α. Because of the unusual way in which TPX2 binds to importin-α, the detailed knowledge of the interaction interface provided by the present crystal structure may facilitate the construction of specific small molecule inhibitors that may interfere with the mitotic TPX2:importin-α interaction while not altering the interphase nuclear protein import function, at least with respect to monopartite NLS-containing cargoes.
Acknowledgments
We thank our colleagues in Cambridge, especially Neil Marshall, Andrew Ellisdon, Florian Gruessing, Rhian Tolvey, and Christoph Brockmann, for many helpful comments, criticisms, and suggestions; Danguole Ciziene for technical assistance; and Jo Westmoreland for illustrations. We thank Mark Allen and Gordon Leonard for data collection at ESRF.
This work was supported in part by a Wellcome Trust Programme grant (to M. S.).
The atomic coordinates and structure factors (code 3KND) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).
- TPX2
- target protein for Xenopus kinesin-like protein 2
- NLS
- nuclear localization sequence
- IBB
- importin-β binding
- DTT
- dithiothreitol
- PDB
- Protein Data Bank
- GST
- glutathione S-transferase
- GFP
- green fluorescent protein.
REFERENCES
- 1.Gruss O. J., Vernos I. (2004) J. Cell Biol. 166, 949–955 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Bastiaens P., Caudron M., Niethammer P., Karsenti E. (2006) Trends Cell Biol. 16, 125–134 [DOI] [PubMed] [Google Scholar]
- 3.Clarke P. R., Zhang C. (2008) Nat. Rev. Mol. Cell Biol. 9, 464–477 [DOI] [PubMed] [Google Scholar]
- 4.Walczak C. E., Heald R. (2008) Int Rev Cytol. 265, 111–158 [DOI] [PubMed] [Google Scholar]
- 5.Cook A., Bono F., Jinek M., Conti E. (2007) Annu. Rev. Biochem. 76, 647–671 [DOI] [PubMed] [Google Scholar]
- 6.Stewart M. (2007) Nat. Rev. Mol. Cell Biol. 8, 195–208 [DOI] [PubMed] [Google Scholar]
- 7.Gruss O. J., Carazo-Salas R. E., Schatz C. A., Guarguaglini G., Kast. J., Wilm M., Le Bot N., Vernos I., Karsenti E., Mattaj I. W. (2001) Cell 104, 83–93 [DOI] [PubMed] [Google Scholar]
- 8.Gruss O. J., Wittmann M., Yokoyama H., Pepperkok R., Kufer T., Silljé H., Karsenti E., Mattaj I. W., Vernos I. (2002) Nat. Cell Biol. 4, 871–879 [DOI] [PubMed] [Google Scholar]
- 9.Tsai M. Y., Wiese C., Cao K., Martin O., Donovan P., Ruderman J., Prigent C., Zheng Y. (2003) Nat. Cell Biol. 5, 242–248 [DOI] [PubMed] [Google Scholar]
- 10.Groen A. C., Maresca T. J., Gatlin J. C., Salmon E. D., Mitchison T. J. (2009) Mol. Biol. Cell 20, 2766–2773 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Kalab P., Heald R. (2008) J. Cell Sci. 121, 1577–1586 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Lange A., Mills R. E., Lange C. J., Stewart M., Devine S. E., Corbett A. H. (2007) J. Biol. Chem. 282, 5101–5105 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Kobe B. (1999) Nat. Struct. Biol. 6, 388–397 [DOI] [PubMed] [Google Scholar]
- 14.Matsuura Y., Stewart M. (2004) Nature 432, 872–877 [DOI] [PubMed] [Google Scholar]
- 15.Matsuura Y., Stewart M. (2005) EMBO J. 24, 3681–3689 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Bibby R. A., Tang C., Faisal A., Drosopoulos K., Lubbe S., Houlston R., Bayliss R., Linardopoulos S. (2009) J. Biol. Chem. 284, 33177–33184 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Brunet S., Sardon T., Zimmerman T., Wittmann T., Pepperkok R., Karsenti E., Vernos I. (2004) Mol. Biol. Cell 15, 5318–5328 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Eckerdt F., Eyers P. A., Lewellyn A. L., Prigent C., Maller J. L. (2008) Curr. Biol. 18, 519–525 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Tulu U. S., Fagerstrom C., Ferenz N. P., Wadsworth P. (2006) Curr. Biol. 16, 536–541 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Conti E., Uy M., Leighton L., Blobel G., Kuriyan J. (1998) Cell 94, 193–204 [DOI] [PubMed] [Google Scholar]
- 21.Lange A., McLane L. M., Mills R. E., Devine S. E., Corbett A. H. (2010) Traffic 11, 311–323 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Conti E., Kuriyan J. (2000) Structure 8, 329–338 [DOI] [PubMed] [Google Scholar]
- 23.Fontes M. R., Teh T., Kobe B. (2000) J. Mol. Biol. 297, 1183–1194 [DOI] [PubMed] [Google Scholar]
- 24.Catimel B., Teh T., Fontes M. R., Jennings I. G., Jans D. A., Howlett G. J., Nice E. C., Kobe B. (2001) J. Biol. Chem. 276, 34189–34198 [DOI] [PubMed] [Google Scholar]
- 25.Hodel M. R., Corbett A. H., Hodel A. E. (2001) J. Biol. Chem. 276, 1317–1325 [DOI] [PubMed] [Google Scholar]
- 26.Hodel A. E., Harreman M. T., Pulliam K. F., Harben M. E., Holmes J. S., Hodel M. R., Berland K. M., Corbett A. H. (2006) J. Biol. Chem. 281, 23545–23556 [DOI] [PubMed] [Google Scholar]
- 27.Fontes M. R., Teh T., Jans D., Brinkworth R. I., Kobe B. (2003) J. Biol. Chem. 278, 27981–27987 [DOI] [PubMed] [Google Scholar]
- 28.Leung S. W., Harremann M. T., Hodel M. R., Hodel A. E., Corbett A. H. (2003) J. Biol. Chem. 278, 41947–41953 [DOI] [PubMed] [Google Scholar]
- 29.Harreman M. T., Kline T. M., Milford H. G., Harben M. B., Hodel A. E., Corbett A. H. (2004) J. Biol. Chem. 279, 20613–20621 [DOI] [PubMed] [Google Scholar]
- 30.Colledge W. H., Richardson W. D., Edge M. D., Smith. A. E. (1986) Mol. Cell. Biol. 6, 4136–4139 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Schatz C. A., Santarella R., Hoenger A., Karsenti E., Mattaj I. W., Gruss O. J., Carazo-Salas R. E. (2003) EMBO J. 22, 2060–2070 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Kapust R. B., Tözsér J., Fox J. D., Anderson D. E., Cherry S., Copeland T. D., Waugh D. S. (2001) Protein Eng. 14, 993–1000 [DOI] [PubMed] [Google Scholar]
- 33.Matsuura Y., Lange A., Harriman M. T., Corbett A. H., Stewart M. (2003) EMBO J. 22, 5358–5369 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Adams P. D., Grosse-Kunstleve R. W., Hung L. W., Ioerger T. R., McCoy A. J., Moriarty N. W., Read R. J., Sacchettini J. C., Sauter N. K., Terwilliger T. C. (2002) Acta Crystallogr. D58, 1948–1954 [DOI] [PubMed] [Google Scholar]
- 35.Painter J., Merritt E. A. (2006) J. Appl. Crystallogr. 39, 109–111 [Google Scholar]
- 36.Emsley P., Cowtan K. (2004) Acta Cryst. D60, 2126–2132 [DOI] [PubMed] [Google Scholar]
- 37.Kosugi S., Hasebe M., Matsumura N., Takashima H., Miyamoto-Sato E., Tomita M., Yanagawa H. (2009) J. Biol. Chem. 284, 478–485 [DOI] [PubMed] [Google Scholar]
- 38.Kosugi S., Hasebe M., Tomita M., Yanagawa H. (2009) Proc. Natl. Acad. Sci., U.S.A. 106, 10171–10176 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Davis I. W., Leaver-Fay A., Chen V. B., Block J. N., Kapral G. J., Wang X., Murray L. W., Arendall W. B., 3rd, Snoeyink J., Richardson J. S., Richardson D. C. (2007) Nucleic Acids Res. 35, W375–W383 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Dias S. M., Wilson K. F., Rojas K. S., Ambrosio A. L., Cerione R. A. (2009) Nat. Struct. Mol. Biol. 16, 930–937 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Dougherty D. A. (1996) Science 271, 163–168 [DOI] [PubMed] [Google Scholar]
- 42.Ems-McClung S. C., Zheng Y., Walczak C. E. (2004) Mol. Biol. Cell 15, 46–57 [DOI] [PMC free article] [PubMed] [Google Scholar]